Latest Press Releases

Health News Posted on Monday, December 11, 2017

Press Releases »

Stock Review for Biotech's Investors -- Cyclacel Pharma, Capricor Therapeutics, Cymabay Therapeutics, and BioDelivery Sciences

NEW YORK , December 11, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on CYCC, CAPR, CBAY, and BDSI which is a click away at www.wallstequities.com/registration . On Friday,...

Read More ...

FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults

Galcanezumab is the first of three investigational, non-opioid treatments in Lilly's pain portfolio ...

Read More ...

Quotidian Technical Highlights on Selected Healthcare Stocks -- Quidel, PetMed Express, Valeant Pharma, and Aradigm

NEW YORK , December 11, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on QDEL, PETS, VRX, and ARDM which is a click away at http://www.wallstequities.com/registration . Marke...

Read More ...

Technical Perspectives on Palatin Technologies, Atossa Genetics, DBV Technologies, and IDEXX Labs

NEW YORK , December 11, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on PTN, ATOS, DBVT, and IDXX which is a click away at http://www.wallstequities.com/registration . Today...

Read More ...

Eating Yogurt May Help Reduce Chronic Inflammation in Women, New Clinical Trial Reveals

New study shows eating low-fat yogurt on a regular basis reduces biomarkers in women of chronic inflammation - a hallmark of obesity, cardiovascular disease and type 2 diabetes ...

Read More ...

Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference

NASDAQ:CRME TSX:COM Plenary Symposium Features Three Experts Discussing Clinical Use VANCOUVER , Dec. 11, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, to...

Read More ...

Anti-venom Market Value to Reach US$2,946 Million by the End of 2025: Transparency Market Research

Global Anti-venom Market: Research and Studies Conducted at International Level Pushes Growth Prospects, says TMR ALBANY, New York , December 11, 2017 /PRNewswire/ -- Presence of several enterprises has rendered the global anti-venom market highly fragmented. In a new study, Transparency Ma...

Read More ...

ApolloMed And Network Medical Management Announce Completion Of Merger And Listing On The Nasdaq Capital Market

MERGER CREATES ONE OF THE LARGEST POPULATION HEALTH MANAGEMENT PLATFORMS IN THE U.S. GLENDALE, Calif. , Dec. 11, 2017 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, and Network Medical Managem...

Read More ...

Anytime Fitness Flexes Development Plans for Mississippi

Fastest-Growing Global Gym Looks to Add 25 New Locations by 2020 ...

Read More ...

Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman

OXFORD, England and DUNDEE, Scotland , December 11, 2017 /PRNewswire/ -- Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of Mr Alex Snow to its Board of Directors as Deputy Chairman. He brings...

Read More ...

Xultophy® Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

BAGSVÆRD, Denmark , December 11, 2017 /PRNewswire/ -- Results published in Diabetes, Obesity and Metabolism     Newly published data from real-world European clinical practice has shown that Xultophy ® (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with ...

Read More ...

Doctors at Fortis Hospitals, Cunningham Road Successfully Treated a Severe Dengue Struck Patient

BANGALORE , December 11, 2017 /PRNewswire/ -- 37-year-old had brain damage and was in coma for 30 days   Doctors at Fortis Hospitals, Cunningham road successfully treated a 37-year-old male patient who was suffering from severe brain damage and coma as a result of dengue fever. The dengu...

Read More ...

Betalutin® Shows Strong Clinical Profile in Relapsed/refractory Indolent NHL and Follicular Lymphoma

Updated data reported at the 59th Annual American Society of Hematology (ASH) meeting Location Phone Number   Norway   +47-2350-0296   Switzerland   +41-44-580-1022   Sweden   +46-8-5065-3942   United   Kingdom and International ...

Read More ...
More Press Releases

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store